tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CATX Stock Latest News

Perspective Therapeutics Updates on Radiopharmaceutical Advancements
Company AnnouncementsPerspective Therapeutics Updates on Radiopharmaceutical Advancements
16d ago
8K
CATX
Perspective Therapeutics price target raised to $16 from $15 at RBC Capital
PremiumThe Fly
Perspective Therapeutics price target raised to $16 from $15 at RBC Capital
16d ago
CATX
Promising Clinical Trial Results and Safety Profile Drive Buy Rating for Perspective Therapeutics
PremiumRatings
Promising Clinical Trial Results and Safety Profile Drive Buy Rating for Perspective Therapeutics
17d ago
CATX
Promising Clinical Updates and Strong Safety Profile Support Buy Rating for Perspective Therapeutics
PremiumRatings
Promising Clinical Updates and Strong Safety Profile Support Buy Rating for Perspective Therapeutics
17d ago
CATX
Perspective Therapeutics Reports Promising Trial Results for [212Pb]VMT-α-NET
PremiumCompany Announcements
Perspective Therapeutics Reports Promising Trial Results for [212Pb]VMT-α-NET
19d ago
8K
CATX
Perspective Therapeutics Holds Annual Stockholders Meeting
PremiumCompany AnnouncementsPerspective Therapeutics Holds Annual Stockholders Meeting
21d ago
8K
CATX
Buy Rating on Perspective Therapeutics: Promising Clinical Data, Strategic Advancements, and Strong Financial Position
Premium
Ratings
Buy Rating on Perspective Therapeutics: Promising Clinical Data, Strategic Advancements, and Strong Financial Position
23d ago
CATX
Optimistic Buy Rating for Perspective Therapeutics Amid Financial Stability and Promising Clinical Developments
Premium
Ratings
Optimistic Buy Rating for Perspective Therapeutics Amid Financial Stability and Promising Clinical Developments
1M ago
CATX
Perspective Therapeutics Reports Q1 2025 Earnings
PremiumCompany Announcements
Perspective Therapeutics Reports Q1 2025 Earnings
1M ago
CATX
Buy Rating for Perspective Therapeutics: Strong Financials and Promising Clinical Progress
PremiumRatings
Buy Rating for Perspective Therapeutics: Strong Financials and Promising Clinical Progress
1M ago
CATX
Perspective Therapeutics Reports Q1 2025 Results and Updates
PremiumCompany Announcements
Perspective Therapeutics Reports Q1 2025 Results and Updates
1M ago
8K
CATX
Buy Rating for Perspective Therapeutics: Promising Advancements in Targeted Radioligand Therapy
PremiumRatings
Buy Rating for Perspective Therapeutics: Promising Advancements in Targeted Radioligand Therapy
2M ago
CATX
Perspective Therapeutics announces first patient dosed with PSV359
PremiumThe FlyPerspective Therapeutics announces first patient dosed with PSV359
2M ago
CATX
Perspective Therapeutics management to meet with Truist
Premium
The Fly
Perspective Therapeutics management to meet with Truist
2M ago
CATX
Tax Day 2025 IRS Payment: Stocks to Consider Buying With the Refund
Premium
Market News
Tax Day 2025 IRS Payment: Stocks to Consider Buying With the Refund
2M ago
CATX
INDI
Optimistic Buy Rating for Perspective Therapeutics Amid Strategic Clinical Developments and Strong Financial Position
PremiumRatings
Optimistic Buy Rating for Perspective Therapeutics Amid Strategic Clinical Developments and Strong Financial Position
2M ago
CATX
Perspective announces first patient dosed in Phase 1/2a trial of 212PbVMT01
PremiumThe Fly
Perspective announces first patient dosed in Phase 1/2a trial of 212PbVMT01
2M ago
CATX
Perspective Therapeutics price target lowered to $10 from $21 at Truist
PremiumThe Fly
Perspective Therapeutics price target lowered to $10 from $21 at Truist
2M ago
CATX
Positive Outlook for Perspective Therapeutics Despite Wider Net Loss, Supported by Strong Cash Position and Upcoming Catalysts
PremiumRatings
Positive Outlook for Perspective Therapeutics Despite Wider Net Loss, Supported by Strong Cash Position and Upcoming Catalysts
3M ago
CATX
Perspective Therapeutics management to meet with Oppenheimer
PremiumThe FlyPerspective Therapeutics management to meet with Oppenheimer
3M ago
CATX
Promising Outlook for Perspective Therapeutics: Buy Rating Affirmed Amid Clinical Progress and Strong Financial Position
Premium
Ratings
Promising Outlook for Perspective Therapeutics: Buy Rating Affirmed Amid Clinical Progress and Strong Financial Position
3M ago
CATX
Perspective Therapeutics Reports 2024 Earnings and Clinical Progress
Premium
Company Announcements
Perspective Therapeutics Reports 2024 Earnings and Clinical Progress
3M ago
CATX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >